About Aspiro Pharma Limited
Data last updated: 06 January 2026
Aspiro Pharma Limited is a public limited company based in Markook, Telangana, India, a subsidiary of Hetero Labs Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 05 February 2014, the company has been in operation for over 12 years.
Registered with ROC Hyderabad under CIN U24100TG2014PLC092771.
Capital: an authorised share capital of ₹1,470.1 Cr and a paid-up capital of ₹1,004.15 Cr. It is led by directors including Bandi Vamsikrishna and Reddy Narsimha.
Last AGM: 24 July 2025. Financial statements filed for year ended 31 March 2025. Office: 321 Biotech Park, Markook, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹418.29 Cr, a growth of 147% compared to the previous year.
The company has a workforce of approximately 408 employees as per the latest available data. It operates as a subsidiary of Hetero Labs Limited. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Aspiro Pharma. As per MCA filings, the company has open charges of ₹206.91 Cr and satisfied charges of ₹46.89 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aspiropharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressPlot No. 23 Survey No.321 Biotech Park Phase – Iii Karkapatla Villa, Ge, Markook, Telangana, India – 502281
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Aspiro Pharma Limited
Aspiro Pharma Limited has one previous CIN (Corporate Identification Number): U24100AP2014PLC092771. The current CIN is U24100TG2014PLC092771, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2014PLC092771 | Current |
| U24100AP2014PLC092771 | Previous |
Associated Brands with Aspiro Pharma Limited
Aspiro Pharma Limited operates one associated brand: Aspiro Pharma. These brands represent Aspiro Pharma Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Research, development, and manufacturing of pharmaceutical formulations in India. | aspiropharma.com |
Business Activity of Aspiro Pharma Limited
Aspiro Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Aspiro Pharma Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Aspiro Pharma Limited
Aspiro Pharma Limited is audited by M.V NARAYANA REDDY & CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M.V NARAYANA REDDY & CO | Locked | Locked | Locked |
Complete auditor history for Aspiro Pharma Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aspiro Pharma Limited
Aspiro Pharma Limited is currently managed by 6 directors, with 15 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Bandi Vamsikrishna
Also directs:
Allita Finvest And Advisors Llp, Eliana Investments And Holdings Llp, Krishn Capital Advisors Llp and 5 more
|
Director | 13 Feb 2014 | 12 Years 6 Months | Current |
| Reddy Narsimha | Director | 03 Aug 2024 | 2 Years 0 Months | Current |
|
Krishnaveni Kura
Also directs:
Editha Infraventures Llp, Jagger Infraventures Llp, Idhant Estate Properties Llp and 5 more
|
Director | 29 Jun 2017 | 9 Years 1 Months | Current |
|
Ramaseshappa Siva Prasad Panchangam
Also directs:
Hetero Healthcare Limited, Lee Pharma Limited
|
Director | 03 Aug 2023 | 3 Years 0 Months | Current |
|
Mahesh Ramappa Kamalamma Hassan
Also directs:
Annora Pharma Private Limited
|
Director | 07 Jun 2023 | 3 Years 2 Months | Current |
| Bhaskarreddy Pabbatireddy | Additional Director | 10 Oct 2025 | 0 Years 10 Months | Current |
Financials of Aspiro Pharma Limited FY 2025 filings available
Aspiro Pharma Limited reported revenue of ₹418.29 Cr (up 147.00% YoY) for FY 2025.
Ten-year financial statements for Aspiro Pharma Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Aspiro Pharma Limited
Shareholding and ownership data for Aspiro Pharma Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Aspiro Pharma Limited
Aspiro Pharma Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Aspiro Pharma Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Strivo Pharma Private Limited | U24302TG2016PTC109188 | Locked |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Aspiro Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2024 | Others | ₹100 Cr | Open |
| 10 May 2024 | Others | ₹9 Lakh | Open |
| 03 Apr 2024 | Others | ₹105 Cr | Open |
| 04 Nov 2023 | Others | ₹13 Lakh | Open |
| 26 Oct 2023 | Others | ₹10.24 Lakh | Open |
Total charge records: 16 View all charges
Employees and EPFO Compliance at Aspiro Pharma Limited
Aspiro Pharma Limited has a workforce of 408 employees as of Apr 06, 2024.
Employee and EPFO history for Aspiro Pharma Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Aspiro Pharma Limited
GST registrations and filing compliance for Aspiro Pharma Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Aspiro Pharma Limited
Credit ratings, litigation, and regulatory alerts for Aspiro Pharma Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aspiro Pharma Limited
MSME payment history for Aspiro Pharma Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aspiro Pharma Limited
Corporate group structure for Aspiro Pharma Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aspiro Pharma Limited
MCA filings and documents for Aspiro Pharma Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Aspiro Pharma Limited
Frequently Asked Questions about Aspiro Pharma Limited
Aspiro Pharma Limited is an active public limited company in the pharma sector based in Markook, Telangana, India. It was incorporated on 05 February 2014 (12+ years old) and is registered under CIN U24100TG2014PLC092771. The company has 408 employees.
Aspiro Pharma Limited reported revenue of ₹418.29 Cr for FY 2025 (up 147.00% YoY).
The current directors of Aspiro Pharma Limited are:
- Bandi Vamsikrishna - Director
- Reddy Narsimha - Director
- Krishnaveni Kura - Director
- Ramaseshappa Siva Prasad Panchangam - Director
- Mahesh Ramappa Kamalamma Hassan - Director
- Bhaskarreddy Pabbatireddy - Additional Director
The primary industry of Aspiro Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Aspiro Pharma Limited can be reached at the registered office: Plot No. 23 Survey No.321 Biotech Park Phase – Iii Karkapatla Villa, Ge, Markook, Telangana, India – 502281, or through the website aspiropharma.com.
The authorised capital is ₹1,470.1 Cr, and the paid-up capital is ₹1,004.15 Cr.